NCT06261268

Brief Summary

The primary objective of this study is to compare changes in peri-implant keratinized mucosa (PIKM) following the application of apically repositioned flap (ARF) using a combination of a Strip graft and a Xenogeneic matrix, or with a free gingival graft (FGG), in implants in the second stage with \<2 mm of PIKM. Additionally, as a secondary objective, the investigators compare postoperative blood supply in both recipient and donor sites based on the type of graft obtained. Meanwhile, the investigators evaluate differences between the two groups concerning microcirculation values (perfusion units, PU), soft tissue thickness (STT), volume change, vestibular depth, as well as clinical, aesthetic, and patient-reported outcome measures (PROMS).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
11mo left

Started Jan 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Jan 2024Apr 2027

First Submitted

Initial submission to the registry

January 16, 2024

Completed
13 days until next milestone

Study Start

First participant enrolled

January 29, 2024

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 15, 2024

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 9, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 9, 2027

Last Updated

April 22, 2026

Status Verified

April 1, 2026

Enrollment Period

3.2 years

First QC Date

January 16, 2024

Last Update Submit

April 17, 2026

Conditions

Keywords

Strip graftFree gingival graftPeri-implant keratinized mucosaSoft tissue augmentationEarly wound healingPostoperative blood supply

Outcome Measures

Primary Outcomes (1)

  • Changes in peri-implant keratinized mucosa width (mm)

    the apico-coronal linear dimension of the buccal peri-implant keratinized mucosa (PIKM) will be measured with a UNC15 periodontal probe (Hu-Friedy manufacturing, Co., LLC, Chicago, USA) as the linear dimension of the buccal vestibule, from the buccal peri-implant mucosa margin to the mucogingival junction at the mid-buccal aspect of the treated implant and adjacent mesial tooth.

    Baseline, 1, 3, 6 and 12 months

Secondary Outcomes (15)

  • Vascularization (in Laser Speckle perfusion units [LSPU])

    pre-surgically, post-surgically at 4, 7, 10, 14 and 30 days, and at 3-6 and 12 months

  • Changes in soft tissue thickness (STT) (mm)

    Baseline, post-op, 1, 3, 6 and 12 months

  • Vestibule depth (VD) (mm)

    Pre-surgically, and at 30 days, 3-6 and 12 months

  • Probing pocket depth (PPD) (mm)

    pre-surgically, at 3, 6 and 12 months after surgery

  • Dehiscence (mm)

    post-surgically, at 3, 6 and 12 months after surgery

  • +10 more secondary outcomes

Study Arms (2)

Strip graft with Mucograft

EXPERIMENTAL

An apically repositioned flap is prepared then, a free epithelialized gingival strip graft is harvested from the molar area of the palate and sutured to the apical part of the recipient area. A xenogeneic collagen matrix (Mucograft®. Geistlich Pharma AG, Wolhusen, Switzerland) covers the remaining uncovered part of the periosteal bed.

Procedure: Strip graft with Mucograft

Free gingival graft

ACTIVE COMPARATOR

Apically repositioned flap is prepared. An epithelialized free gingival graft is harvested from the molar area of the palate, and sutured to the recipient area

Procedure: Free gingival graft

Interventions

An apically repositioned flap is made in the vestibular region. The flap is then elevated with a split-thickness preparation, and the mucogingival junction will be repositioned apically and fixed with periosteal-anchored sutures. Then, a free epithelialized gingival strip graft will be harvested from the molar area of the palate. The "Strip" graft is sutured to the apical end of the recipient bed. The remaining uncovered part of the periosteal bed will be covered with a xenogeneic collagen matrix (Mucograft®. Geistlich Pharma AG, Wolhusen, Switzerland) fixed with simple interrupted and crossed sutures. The edges of the palatal wound (donor area) will be approximated with crossed sutures.

Strip graft with Mucograft

The preparation of the apically repositioned flap and the recipient bed with its apico-coronal design and dimension is performed as in the test group. Subsequently, an epithelialized free gingival graft with the size of the entire recipient area with a thickness of 2 mm will be harvested from the molar area of the palate. The graft is sutured to the recipient periosteal bed using simple interrupted and crossed sutures. In the donor area, a collagen sponge is sutured to the wound by means of crossed sutures.

Free gingival graft

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients older than 18 years
  • Short-span dental implants in the mandible at second stage with inadequate PIKM (\<2 mm) with at least one adjacent tooth mesially
  • Periodontally healthy patients with a pristine or reduced periodontium
  • Plaque index (FMPS) less than 20%.

You may not qualify if:

  • Compromised general health status that contraindicates study procedures (≥ASA III);
  • Drug or alcohol abuse;
  • Smoking of \> 10 cigarettes per day;
  • Chronic use of corticosteroids, NSAIDs or immunomodulators (any type or dose);
  • Pregnant or lactating women;
  • History of previous mucogingival surgeries in the area of interest

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Complutense University

Madrid, Madrid, 28040, Spain

Location

Related Publications (6)

  • Ramanauskaite A, Schwarz F, Sader R. Influence of width of keratinized tissue on the prevalence of peri-implant diseases: A systematic review and meta-analysis. Clin Oral Implants Res. 2022 Jun;33 Suppl 23:8-31. doi: 10.1111/clr.13766.

    PMID: 35763022BACKGROUND
  • Sanz M, Schwarz F, Herrera D, McClain P, Figuero E, Molina A, Monje A, Montero E, Pascual A, Ramanauskaite A, Renouard F, Sader R, Schiegnitz E, Urban I, Heitz-Mayfield L. Importance of keratinized mucosa around dental implants: Consensus report of group 1 of the DGI/SEPA/Osteology Workshop. Clin Oral Implants Res. 2022 Jun;33 Suppl 23:47-55. doi: 10.1111/clr.13956.

    PMID: 35763021BACKGROUND
  • Montero E, Molina A, Matesanz P, Monje A, Sanz-Sanchez I, Herrera D. Efficacy of soft tissue substitutes, in comparison with autogenous grafts, in surgical procedures aiming to increase the peri-implant keratinized mucosa: A systematic review. Clin Oral Implants Res. 2022 Jun;33 Suppl 23:32-46. doi: 10.1111/clr.13751.

    PMID: 35763018BACKGROUND
  • Solonko M, Regidor E, Ortiz-Vigon A, Montero E, Vilchez B, Sanz M. Efficacy of keratinized mucosal augmentation with a collagen matrix concomitant to the surgical treatment of peri-implantitis: A dual-center randomized clinical trial. Clin Oral Implants Res. 2022 Jan;33(1):105-119. doi: 10.1111/clr.13870. Epub 2021 Oct 21.

    PMID: 34651349BACKGROUND
  • Urban IA, Lozada JL, Nagy K, Sanz M. Treatment of severe mucogingival defects with a combination of strip gingival grafts and a xenogeneic collagen matrix: a prospective case series study. Int J Periodontics Restorative Dent. 2015 May-Jun;35(3):345-53. doi: 10.11607/prd.2287.

    PMID: 25909521BACKGROUND
  • Molnar E, Molnar B, Lohinai Z, Toth Z, Benyo Z, Hricisak L, Windisch P, Vag J. Evaluation of Laser Speckle Contrast Imaging for the Assessment of Oral Mucosal Blood Flow following Periodontal Plastic Surgery: An Exploratory Study. Biomed Res Int. 2017;2017:4042902. doi: 10.1155/2017/4042902. Epub 2017 Jan 23.

    PMID: 28232940BACKGROUND

Related Links

MeSH Terms

Conditions

Surgical Wound

Interventions

Mucograft

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Officials

  • Mariano Sanz Alonso

    Universidad Complutense de Madrid

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A randomized controlled equivalence clinical trial will be performed, with two parallel groups, a 1:1 allocation ratio, and a 12-month follow-up.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 16, 2024

First Posted

February 15, 2024

Study Start

January 29, 2024

Primary Completion (Estimated)

April 9, 2027

Study Completion (Estimated)

April 9, 2027

Last Updated

April 22, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations